Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000583978 | SCV000687890 | likely benign | Hereditary cancer-predisposing syndrome | 2017-01-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000796169 | SCV000935668 | likely benign | BAP1-related tumor predisposition syndrome | 2024-11-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000583978 | SCV001169827 | likely benign | Hereditary cancer-predisposing syndrome | 2015-06-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001764702 | SCV002008479 | uncertain significance | not provided | 2019-06-06 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 30395583) |
Myriad Genetics, |
RCV000796169 | SCV005406103 | benign | BAP1-related tumor predisposition syndrome | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |